Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases

Read full text
Authors: Alok Jaiswal, Tristan Kooistra, Vladislav Pokatayev, Hélder N. Bastos, Rita F. Santos, Tresa Rani Sarraf, Åsa Segerstolpe, Crystal Lin, Liat Amir-Zilberstein, Shaina W. Twardus, Kevin Shannon, Shane P. Murphy
+11 more Rachel S. Knipe, Ingo Ganzleben, Katharine E. Black, Toni Delorey, D. B. Graham, Yin P. Hung, Lida P. Hariri, Jacques Deguine, Agostinho Carvalho, Benjamin D. Medoff, Ramnik J. Xavier
Cited by: 6
References: 78

Abstract

Interstitial lung diseases (ILD) are characterized by fibrotic scarring of the lung parenchyma with remarkably unfavorable prognosis. Using single-nucleus RNA sequencing and spatial transcriptomics, we generated a comprehensive cellular network of the distal lung and its alterations in fibrosis. Integration with histopathology revealed that the transformation of normal parenchyma into fibrotic tissue is accompanied by ectopic bronchiolization and decellularization. Areas of active fibrosis were characterized by co-localization of pro-fibrotic CTHRC1-hi fibroblasts and aberrant transitional epithelial cells. We modeled this maladaptive differentiation of alveolar epithelial cells using organoids, demonstrating that all three pro-inflammatory ligands present in this pathogenic niche, TGF-β, IL-1β, and TNF-α, are jointly required for their induction. Additionally, we identified a requirement for the transcription factor NFATC4 during myofibroblast differentiation driven by soluble factors or mechanosensing. Collectively, this work identifies essential molecular drivers of the cellular interactions underlying lung fibrosis.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Neonatal Respiratory Health Research Connective Tissue Growth Factor Research

Publication details

Journal / source
Cell Genomics
Publisher
Elsevier BV
Volume
6
Issue
3
Pages
101066–101066
Publication date
22 January 2026
Language
EN